Scintillation Nanotechnologies Inc.

Vail, AZ Doing business as Scientific Manufacturing

UEI
LWZ3EXG6XRZ9
CAGE
87MY5
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
13889 E Placita Propia, Vail, AZ 85641, USA
Website
sntnano.com
Founded
2018
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Life Sciences Tools & Services
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Similar vendors

About the company

Scintillation Nanotechnologies Inc., doing business as Scientific Manufacturing, is a for-profit corporate entity and manufacturer of goods registered to receive awards from the U.S. federal government since November 2018. The company specializes in developing innovative nanomaterials for sensitive detection of low-energy radioisotopes in aqueous samples. Their proprietary, IP-protected core-shell nanomaterials, including a product called NanoSPA, are designed to overcome limitations of traditional radioisotope counting methods and enable new high-sensitivity biomolecular analyses. These advanced materials have applications in biomedical research and drug discovery, particularly for detecting and measuring compounds that are challenging to analyze using conventional optical or electrochemical methods.

The company has received multiple Project Grant awards from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). These grants have supported the continued development and characterization of their nanomaterials for various applications. One project focused on creating nanomaterials for sensitive binding assays with G protein-coupled receptors (GPCRs) in native membrane compositions, providing a more complete picture of protein functionality. Another grant supported the development of nanomaterials for real-time, molecularly selective detection of low-energy radioisotopes directly in aqueous samples, with potential applications in intracellular measurements. Additionally, Scintillation Nanotechnologies Inc. has worked on enhancing the surface functionalization of their NanoSPA product to expand its capabilities for biomedical research, particularly in drug discovery applications such as ligand-receptor binding assays. These projects aim to facilitate investigations of biological systems using common radioisotope labels like 32P, 33P, 35S, and 3H, ultimately leading to transformational improvements in biomolecular detection and measurement capabilities.

Quick answers

Is Scintillation Nanotechnologies Inc. registered in SAM.gov?

Yes. Scintillation Nanotechnologies Inc.'s SAM.gov registration is active through March 12, 2027.

What is Scintillation Nanotechnologies Inc.'s most recent federal award?

Scintillation Nanotechnologies Inc.'s most recent federal grant award is Nanoparticle radioassay for proteins in native membranes - the capability to analyze cellular uptake of physiological… (R43GM154590), from National Institute of General Medical Sciences (NIH), on May 3, 2024.

On GovTribe

See Scintillation Nanotechnologies Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors